Background Image
Table of Contents Table of Contents
Previous Page  2 / 67 Next Page
Information
Show Menu
Previous Page 2 / 67 Next Page
Page Background

Our

BIG 3

S3 Reg. No. 41/7.1.3/0671, 72

S3 Reg. No. 39/7.1/0117, 0120

S4 Reg. No. 42/7.5/0552, 0553, 0554, 0555

team

Trus t ed

Ev idence based

Af f ordab l e

Med i c i ne

Amlodipine Besylate 5 mg / 10 mg

A c omp e l l i n g c h o i c e f o r ma n y p a t i e n t s a t

mo d e r a t e c v r i s k w h o d o c t o r s s e e e v e r y

d a y – “

d emo n s t r a t e s t h a t t h e r i s k

o f h e a r t a t t a c k s c a n b e

mo r e t h a n

h a l v e d

i n t h e s e p a t i e n t s ”

1

Cipla Medpro (Pty) Ltd. Reg. No. 1995/004182/07, Rosen Heights, Pasita Street, Rosen Park, Bellville, 7530. Tel (021) 943 4200, Fax (021) 914 4699.

E-mail:

medicalpa@ciplamedpro.co.za

Website:

www.cipla.co.za

Perindopril Erbumine 4 mg / 8 mg

REFERENCE:

1. Sever P, et al. Potential synergy between lipid lowering and blood pressure lowering in the Anglo-Scandinavian

Cardiac Outcomes Trial lipid-Lowering Arm. European Heart Journal 2006, Volume 27; 24: 2982-2988

Atorvastatin

10 mg

,

20 mg

,

40 mg

,

80 mg